Company
Novo Nordisk
- Biotech
- Founded:
- 1923
- Location:
- Bagsværd, Denmark
- Parent:
- Novo Holdings
Description
Novo Nordisk develops treatments and support for serious chronic diseases by applying scientific expertise and understanding of people’s lives, with medicines authorized for approved indications in local countries or regions.
Novo Nordisk is located in the Copenhagen ecosystem.
Related
NovonesisSame parentNovonesis brings sales and distribution together with research and innovation for animal feed enzymes, microbes, and probiotics, supporting…
Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
CamurusCamurus develops and commercializes long-acting pharmaceutical medicines using its proprietary FluidCrystal technology for treatment of…
LEO PharmaLEO Pharma develops and delivers innovative treatments for medical dermatology, producing medicines and supplying healthcare providers and…
SNIPR BIOMESNIPR BIOME develops CRISPR-based medicines that use bacteriophages, engineered probiotics, and CRISPR systems to target…
Neurent MedicalNeurent Medical develops the NEUROMARK System, a radiofrequency-based ENT medical device that targets posterior nasal nerves to provide…
ALK-Abelló A/SALK-Abelló A/S develops allergy immunotherapy treatments and management solutions using natural allergens, including grass pollen and house…
Jazz PharmaceuticalsJazz Pharmaceuticals develops and commercializes medicines for people with rare diseases, focusing on therapies for epilepsies, cancers and…
SulfateqSulfateq develops SUL compounds from research into natural mitochondrial stress responses, using a distinct mechanism of action to address…